The need for antibiotic stewardship and treatment standardization in the care of cirrhotic patients with spontaneous bacterial peritonitis - a retrospective cohort study examining the effect of ceftriaxone dosing

F1000Research

Volumn 3, Issue , 2014, Pages

  Mazer, Laura ^a   Tapper, Elliot B ^b   Piatkowski, Gail ^b   Lai, Michelle ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b Division of Endocrinology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE;

ADULT; ANTIBIOTIC STEWARDSHIP; ARTICLE; BACTERIAL PERITONITIS; COHORT ANALYSIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; FEMALE; HUMAN; INTENSIVE CARE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; PATIENT CARE; PHARMACEUTICAL CARE; RETROSPECTIVE STUDY; STANDARDIZATION; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 84916620192     PISSN: 20461402     EISSN: 1759796X     Source Type: Journal    
DOI: 10.12688/f1000research.3-57.v2     Document Type: Article

References (20)

1. Runyon BA : AASLD Practice Guidelines Committee: Management of adult patients with ascites due to cirrhosis: an update. Hepatology. 2009;49(6):2087-2107. 19475696 10.1002/hep.22853
2. Ginès P Cárdenas A Arroyo V : Management of cirrhosis and ascites. N Engl J Med. 2004;350(16):1646-1654. 15084697 10.1056/NEJMra035021
3. Planas R Montoliu S Ballesté B : Natural history of patients hospitalized for management of cirrhotic ascites. Clin Gastroenterol Hepatol. 2006;4(11):1385-1394. 17081806 10.1016/j.cgh.2006.08.007
4. Rimola A García-Tsao G Navasa M : International Ascites Club: Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. J Hepatol. 2000;32(1):142-153. 10673079 10.1016/S0168-8278(00)80201-9
5. Thuluvath PJ Morss S Thompson R : Spontaneous bacterial peritonitis--in-hospital mortality, predictors of survival, and health care costs from 1988 to 1998. Am J Gastroenterol. 2001;96(4):1232-6. 11316175 10.1111/j.1572-0241.2001.03708.x
6. Ginès P Guevara M Arroyo V : Hepatorenal syndrome. Lancet. 2003;362(9398):1819-27. 14654322 10.1016/S0140-6736(03)14903-3
7. Follo A Llovet JM Navasa M : Renal impairment after spontaneous bacterial peritonitis in cirrhosis: Incidence, clinical course, predictive factors and prognosis. Hepatology. 1994;20(6):1495-1501. 7982650 10.1002/hep.1840200619
8. Cartier M Terg R Lucero R : Pilot study: Gelafundin (polygeline) 4% plus antibiotics in the treatment of high-risk cirrhotic patients with spontaneous bacterial peritonitis. Aliment Pharmacol Ther. 2010;32(1):43-48. 20345510 10.1111/j.1365-2036.2010.04309.x
9. Baskol M Gursoy S Baskol G : Five days of ceftriaxone to treat culture negative neutrocytic ascites in cirrhotic patients. J Clin Gastroenterol. 2003;37(5):403-405. 14564189 10.1097/00004836-200311000-00011
10. França AV De Souza JB Silva CM : Long-term prognosis of cirrhosis after spontaneous bacterial peritonitis treated with ceftriaxone. J Clin Gastroenterol. 2001;33(4):295-298. 11588542
11. Javid G Khan BA Khan BA : Short-course ceftriaxone therapy in spontaneous bacterial peritonitis. Postgrad Med J. 1998;74(876):592-595. 10211351 10.1136/pgmj.74.876.592 2361012
12. Mesquita MA Balbino EP Albuquerque RS : Ceftriaxone in the treatment of spontaneous bacterial peritonitis: ascitic fluid polymorphonuclear count response and short-term prognosis. Hepatogastroenterology. 1997;44(17):1276-80. 9356840
13. Gómez-Jiménez J Ribera E Gasser I : Randomized trial comparing ceftriaxone with cefonicid for treatment of spontaneous bacterial peritonitis in cirrhotic patients. Ant Ag Chemo. 1993;37(8):1587-1592. 8215267 10.1128/AAC.37.8.1587 188024
14. Mercader J Gomez J Ruiz J : Use of ceftriaxone in the treatment of bacterial infections in cirrhotic patients. Chemotherapy. 1989;35(Suppl 2):23-6. 2612236 10.1159/000238735
15. Pham PA Bartlett JG : Ceftriaxone. Johns Hopkins POC-IT Center. 9/24/2010.
16. Runyon BA : AASLD Practice Guidelines Committee: Management of adult patients with ascites due to cirrhosis: an update. Hepatology. 2009;49(6):2087-2107. 19475696 10.1002/hep.22853
17. European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53(3):397-417. 20633946 10.1016/j.jhep.2010.05.004
18. Runyon BA : AASLD Practice Guidelines Committee: Management of adult patients with ascites due to cirrhosis: an update. Hepatology. 2009;49(6):2087-107. 19475696 10.1002/hep.22853
19. Steib A Jacoberger B Von Bandel M : Concentrations in plasma and tissue penetration of ceftriaxone and ornidazole during liver transplantation. Antimicrob Agents Chemother. 1993;37(9):1873-6. 8239599 10.1128/AAC.37.9.1873 188085
20. Laura M Elliot BT Gail P : Spontaneous bacterial peritonitis outcome and ceftriaxone dosage data. figshare. 2014. Data Source